miR-138 inhibits proliferation by targeting 3-phosphoinositide-dependent protein kinase-1 in non-small cell lung cancer cells

MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells

(2014) Vita Golubovskaya et al.   Anti-Cancer Agents in Medicinal Chemistry

MiR-138 Inhibits Tumor Growth Through Repression of EZH2 in Non-Small Cell Lung Cancer

(2013) Huijun Zhang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Downregulation of EIF4A2 in Non–Small-Cell Lung Cancer Associates with Poor Prognosis

(2013) Xi Shaoyan et al.   Clinical Lung Cancer

Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases

(2013) Frank P Vendetti et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Survival, Classifications, and Desmosomal Plaque Genes in Non-Small Cell Lung Cancer

(2013) Laura Boyero et al.   International Journal of Medical Sciences

Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma

(2011) Dan Liu et al.   CANCER

MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2

(2011) Ji-guang Zhang et al.   Journal of Thoracic Oncology

MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)

(2010) Ji-guang Zhang et al.   CLINICA CHIMICA ACTA

miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc

(2010) Zhe Chen et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer

(2010) P. Ceppi et al.   MOLECULAR CANCER RESEARCH

MiR-107 and MiR-185 Can Induce Cell Cycle Arrest in Human Non Small Cell Lung Cancer Cell Lines

(2009) Yukari Takahashi et al.   PLoS One

MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines

(2008) M. Crawford et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

(2008) Giorgio Vittorio Scagliotti et al.   JOURNAL OF CLINICAL ONCOLOGY

Somatic mutations affect key pathways in lung adenocarcinoma

(2008) Li Ding et al.   NATURE

Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

(2008) Kerby Shedden et al.   NATURE MEDICINE